The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.
Zacks Investment Research on MSN
Medtronic (MDT) Stock Dips While Market Gains: Key Facts
Medtronic (MDT) closed the most recent trading day at $94.21, moving -1.76% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.58%. At the same time, ...
Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable ...
Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...
The firm stated that Medtronic plc (NYSE:MDT) seems “confidently ready” from the standpoints of manufacturing, supply chain, ...
In the last decade, Medtronic (MDT) stock has returned a notable $52 Bil back to its shareholders through cold, hard cash via ...
Techsomed Ltd., an Israel-based developer of medical artificial intelligence–powered software for image-guided therapy, a ...
The companies agreed to enhance access to technology from DASI, a leader in AI-driven predictive modeling and digital twin ...
Medtronic (MDT) just announced the launch of a new clinical study in the U.S. that will test its Hugo robotic-assisted ...
After a long delay, the U.S. Food and Drug Administration has approved Medtronic's MiniMed 780G device, the company's next-generation insulin pump. Medtronic's diabetes division has been under a ...
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results